Skip to main content
Hannah Joseph Hospital Limited logo

Hannah Joseph Hospital Limited — Investor Relations & Filings

Ticker · 544687 ISIN · INE0JVH01012 BSE.NS Human health and social work activities
Open in API
Filings indexed 28 across all filing types
Latest filing 2026-05-29 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 544687

About Hannah Joseph Hospital Limited

https://hannahjosephhospital.com/

Hannah Joseph Hospital Limited is a specialized healthcare institution primarily focused on neurosurgery and neurology. The hospital provides comprehensive medical services including advanced brain and spine surgeries, neuro-oncology, and trauma care. It is equipped with modern diagnostic and surgical technologies such as high-definition operating microscopes, neuronavigation systems, and advanced imaging facilities. The facility operates a dedicated stroke unit and intensive care units to manage complex neurological emergencies. Beyond its core focus, the hospital offers services in orthopedics, ENT, and general medicine, supported by a multidisciplinary team of specialists. The institution emphasizes patient-centric care through integrated rehabilitation programs and 24/7 emergency medical support.

Recent filings

Filing Released Lang Actions
We wish to inform you that the Board of Directors of the Company at their meeting held on 29.05.2026 has recommended a final dividend of Rs.2/- per equity share of face value of Rs.10/- ....
Interim / Quarterly Report Classification · 92% confidence The document is an official disclosure to the BSE under SEBI LODR Regulations 30 and 33 announcing the outcome of the Board meeting held May 29, 2026. It includes the audited financial results for the half year and full financial year ended March 31, 2026, complete with balance sheet, profit & loss, cash flow statements and notes. It is not a brief earnings summary (ER) nor a full annual report (10-K); rather it is the statutory half-year/annual audited financial results filing with full statements. This aligns with an Interim / Quarterly Report (IR) category. FY 2026
2026-05-29 English
Re-Appointment of Internal Auditors for the Financial Year 2026-27
Regulatory Filings Classification · 85% confidence The document is a stock exchange disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, announcing the re-appointment of the company’s internal auditor. It is not an actual audit report, annual/interim financial report, or management/board member appointment. It is a routine regulatory announcement of a material event. Therefore, it falls under the general Regulatory Filings category.
2026-05-29 English
Statement on deviation or variation for half year ended 31.03.2026
Regulatory Filings Classification · 88% confidence The document is a half‐yearly compliance filing under SEBI Listing Regulations (Reg.32) reporting on the “Statement on Deviation or Variation in utilization of IPO proceeds” together with an auditor’s certificate. It is not an earnings or annual/interim report, nor an approval/announcement of a specific board change, share issue, or dividend. It is a regulatory disclosure filed with the exchange, so it falls under the general “Regulatory Filings” category (RNS).
2026-05-29 English
Audited Financial Results for the Half year and year ended March 31, 2026
Interim / Quarterly Report Classification · 85% confidence The document is the official Board meeting outcome under SEBI LODR Reg 30 & 33, containing the Audited Financial Results for the half‐year and financial year ended March 31, 2026, along with full financial statements (statement of assets & liabilities, profit & loss, cash flows, notes, and auditor’s report). It is not a short announcement (RPA/RNS) nor just highlights (ER); it includes substantive interim-period financial data (six months) and detailed statements. This aligns with our definition of an Interim / Quarterly Report (IR). FY 2026
2026-05-29 English
The Board of Directors of the Company at their meeting held on 29.05.2026, inter alia, approved the following: 1. Audited Financial Results for the half year and financial year ended 31st ....
Interim / Quarterly Report Classification · 90% confidence The document is a detailed set of audited financial results for the half‐year and full financial year ended March 31, 2026, including full statements of assets & liabilities, profit & loss, cash flows, notes and the Independent Auditor’s Report. It was filed under SEBI LODR Regulations as an “Outcome of Board Meeting” and contains substantive financial data rather than just a brief earnings highlight or an announcement of a report. This matches the definition of an Interim/Quarterly Report (IR) because it covers a half‐year period with complete financial statements—not merely a summary or certification. FY 2026
2026-05-29 English
Hannah Joseph Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Revised Prior Intimation ....
Regulatory Filings Classification · 85% confidence The document is an official regulatory notice under SEBI Listing Regulations, intimating the stock exchange of a forthcoming Board meeting to consider and approve audited financial results and recommend dividends. It does not contain actual financial results or changes in management, but is a compliance/regulatory announcement. Hence, it falls under the general “Regulatory Filings” category (RNS).
2026-05-21 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.